Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.38 |
| ▸ | LTA4H | P09960 | 1/20 | 0.37 |
| ▸ | ADRA1D | P25100 | 3/20 | 0.36 |
| ▸ | ADRA1A | P35348 | 3/20 | 0.36 |
| ▸ | ADRA1B | P35368 | 3/20 | 0.36 |
| ▸ | HRH3 | Q9Y5N1 | 3/20 | 0.36 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.36 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.35 |
| ▸ | CHIT1 | Q13231 | 1/20 | 0.35 |
| ▸ | CHIA | Q9BZP6 | 1/20 | 0.35 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8273684 | 0.85 | CHI3L1 (0.46) | ALDH1A1HRH3KDM4EKCNH2CHIT1 | |
| SCHEMBL19786306 | 0.84 | LTA4H (0.38) | LTA4HADRA1DADRA1AADRA1BHRH3 | |
| SCHEMBL4278447 | 0.69 | CHRNB2 (0.49) | ALDH1A1ADRA1DADRA1AADRA1BHRH3 | |
| SCHEMBL11486276 | 0.68 | ALDH1A1 (0.51) | ALDH1A1KDM4EKCNH2CHIT1CHIA | |
| SCHEMBL10462905 | 0.68 | SPHK2 (0.50) | ALDH1A1KDM4EMAPK1 | |
| SCHEMBL11486228 | 0.68 | CHRNB2 (0.48) | ALDH1A1ADRA1DADRA1AADRA1BHRH3 | |
| SCHEMBL11474181 | 0.68 | DRD2 (0.48) | — | |
| SCHEMBL11473707 | 0.68 | ALDH1A1 (0.49) | ALDH1A1 | |
| SCHEMBL19828345 | 0.68 | CHRM5 (0.33) | — | |
| SCHEMBL350911 | 0.68 | HSD11B1 (0.48) | HSD11B1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200131358-A1 | In-Situ Polymer Blend for a Tire | SYNTHOS DWORY 7 SPOLKA Z OGRANICZONA ODPOWIEDZIALNOSCIA (PL) | 2020-04-30 | — | — | US | disclosed |
| US-20200071505-A1 | IN-SITU POLYMER BLEND FOR A TIRE | TRINSEO EUROPE GMBH (CH) | 2020-03-05 | — | — | US | disclosed |
| US-20200055881-A1 | MULTIVINYLAMINOSILANES AS BRANCHING AGENTS FOR FUNCTIONALIZED ELASTOMERIC POLYMERS | TRINSEO EUROPE GMBH (CH) | 2020-02-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200055881-A1 | MULTIVINYLAMINOSILANES AS BRANCHING AGENTS FOR FUNCTIONALIZED ELASTOMERIC POLYMERS | PRUNE1, GNE, TERB1 | ALDH1A1 2357/4885LTA4H 1141/4885ADRA1D 2201/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.